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ABSTRACT
Ghrelin Concentrations in Milk and Plasma of Dairy Cows
during Early Lactation
by

Sameer M. Alhojaily, Master of Science
Utah State University, 2013

Major Professor: Dr. Allen J. Young
Department: Animal, Dairy & Veterinary Science
Ghrelin is a 28 amino acid octanoylated peptide hormone and is the only naturally
occurring peptide with post translation modification by ser3 O-octanoylation. This
modification is essential for ghrelin activity and, subsequently, activation of its specific
receptor. Active ghrelin binds to growth hormone secretagogue receptor (GHS-R), which
stimulates growth hormone release and appetite. Ghrelin is expressed and produced in
several tissues, but the gastric mucosa is the major source of circulating ghrelin. Ghrelin
is a hormone with multiple functions and diverse biological actions. The acylated ghrelin
is the only known biologically active form of ghrelin while the majority of circulating
ghrelin is des-acylated ghrelin with no identified function. The aims of the present study
were to measure active and total ghrelin in dairy cow’s milk and plasma during early
lactation, and to observe changes in the ghrelin concentrations over time. Fifteen Holstein
dairy cows were selected randomly from different lactations. Milk and blood samples
were taken daily from cows at early lactation (n=10), from day 1 to day 10 in milk, and
from cows in mid-lactation (n=5), averaging 227 DIM, for one day. An ELISA assay was
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used to measure active and total ghrelin in milk and plasma samples. Other measurements
such as milk fat, lactose, protein, SCC, MUN, and milk yield were recorded. Active and
total milk ghrelin concentrations were found to be significantly higher in the first day of
lactation (P ≤ 0.05). No significant difference was found in the percentage of active to
total ghrelin in milk and blood, suggesting that this constant ratio can be used to estimate
active or total ghrelin, if one of them is know, from the same sample. Plasma ghrelin
concentrations were not significantly different across days, with a constant percentage of
active to total ghrelin. No correlation was observed between milk and plasma active and
total ghrelin. Presence of ghrelin in colostrum and milk in measurable amounts of both
active and total form (acylated and des-acylated) suggests that it is a critical compound
for the metabolic activity of newborn calves and functions transiently to regulate the
activity of some physiological processes until the endocrine system of the new calves
starts to function independently.
(51 pages)
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PUBLIC ABSTRACT
Ghrelin Concentrations in Milk and Plasma of Dairy
Cows during Early Lactation
Sameer M. Alhojaily
Ghrelin is a hormone produced mainly by the cells lining the gastric mucosa.
Ghrelin was first extracted from human and rat stomachs, and identified as an
endogenous stimulator of growth hormone release. Ghrelin is synthesized and produced
in several tissues, but the gastric mucosa remains the major source of circulating ghrelin.
Besides growth hormone release, ghrelin stimulates appetite and plays some major roles
in different organs. In several studies, ghrelin was described as a hormone with multiple
functions and diverse biological actions. Ghrelin exists in two major forms, active ghrelin
and inactive ghrelin, and only the active from binds to the receptor. The majority of total
circulating ghrelin is inactive ghrelin with no identified function. The aims of the present
study were to measure active and total ghrelin in dairy cow’s milk and plasma during
early lactation, and to observe changes in the ghrelin concentrations over time. We are
interested in this period of time since the milk during early lactation contains a variety of
biologically active hormones that are vital for newborn calves. In this study, fifteen
Holstein dairy cows were selected randomly from different lactations. Milk and blood
samples were taken daily from cows at early lactation for 10 days, and from some cows
in mid-lactation. A laboratory test was used to measure active and total ghrelin in milk
and plasma samples. Supplementary measurements such as milk fat, lactose, protein, and
milk yield were recorded. Active and total milk ghrelin concentrations were found to be
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significantly higher in the first day of lactation during colostrum production. Interstingly,
the percentage of active to total ghrelin in milk and blood was constant in all days tested,
suggesting that this constant percentage can be used to estimate active or total ghrelin, if
one of them is know, from the same sample. However, no correlation was observed
between the percentage of milk ghrelin and plasma ghrelin or with other milk
components. In conclusion, the presence of ghrelin in colostrum and milk in measurable
amounts of both active and total form suggests that it is a critical compound for the
metabolic activity of newborn calves and functions transiently to regulate the activity of
some physiological processes until the endocrine system of the new calves starts to
function independently.
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INTRODUCTION
Milk is the main source of nutrition for the newborn calves and it contains a
variety of biologically active nutrients and hormones that immediately benefit the
newborn. Hormones in milk function to transiently regulate some of the physiological
activity of some tissues until the neonate’s endocrine systems begin to function
independently. Early life nutrition is a critical factor that plays an important role in longterm appetite control and it regulates feeding mechanisms in the central nervous system.
The fetus, during gestation, is completely dependent on maternal nutrition and
stimulating feeding behavior after birth is critical for survival. There are several factors of
orexigenic effect essential in early nutrition that are secreted from the peripheral tissues.
Among the known orexigenic factors, ghrelin hormone has been found to be the most
powerful appetite stimulator.
Ghrelin is present in human milk in considerable amounts and its mRNA have
been identified in the mammary gland tissue (Aydin et al., 2006; Kierson et al., 2006).
Ghrelin is a 28 amino acid octanoylated peptide hormone and known to be the only
naturally occurring peptide with post translation modification by ser3 O-octanoylation
(Kojima and Kangawa, 2010). This modification is essential for ghrelin activity and
subsequently, activation of its specific receptor (Date et al., 2000a). Ghrelin binds to
growth hormone secretagogue receptor 1a (GHS-R1a) which is expressed extensively in
the brain and hypothalamus (Kojima et al., 1999; Kojima and Kangawa, 2005). Ghrelin
was first isolated from the rat and human stomach mucosa (Kojima et al., 1999) and it has
been identified in several tissues (Gnanapavan et al., 2002; Korbonits et al., 2004), but
the gastric mucosa remains the major source of circulating ghrelin. Ghrelin circulates in
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the blood in two major forms, acylated (active form) and des-acylated form (Soares and
Leite-Moreira, 2008).
Ghrelin was discovered as an endogenous ligand for GHS-R1a and was first
identified to stimulate the release of growth hormone, in both in vivo and in vitro
(Kojima et al., 1999; Kojima et al., 2001). Further studies later revealed that ghrelin is a
hormone with multifunctions and is involved in the regulation of food intake behavior,
energy homeostasis, tissue growth and development, reproduction and gastrointestinal
functions (Korbonits et al., 2004; Kojima and Kangawa, 2010).
Since ghrelin has an appetite stimulating effect and growth hormone releasing
activity, it can potentially moderate the effect of anorexia in newborn calves, increase
body weight gain, and potentially improve the resistance to pathological and
environmental challenges during early life. Body weight and early life health condition is
the best predictor of productive and reproductive performance in the future. In the case of
ghrelin hormone, it has been reported that there is a positive relation between the ghrelin
concentration in the serum of breast fed infants and its concentration in the breast milk in
human (Ilcol and Hizli, 2007). Also, administration of ghrelin, via the stomach tube in
piglets, resulted in significant changes in the small intestinal morphometry and mucosal
development (Slupecka et al., 2012).
To our knowledge, the effect of ghrelin on claves has not yet been studied and the
amount of ghrelin in bovine milk has not been identified in a detailed study. Savino et al.
(2011) measured ghrelin level of non-pasteurized cow’s milk to compare with breast milk
and some milk formula. The total ghrelin in the cow’s milk was reported to be 2.82
ng/ml. Several studies have identified ghrelin plasma level in cattle (Jennings et al., 2011;
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Borner et al., 2013; Field et al., 2013; Ozturk et al., 2013), but none of these have
determined the relation between milk ghrelin and plasma ghrelin, or the ratio between
acylated (active ghrelin) and des-acylated ghrelin in cattle.
The primary aim of the present study was to investigate the level of ghrelin
concentrations in colostrum, transitional milk, early lactation mature milk, and midlactation milk and plasma. The colostrum and milk of the first week are particularly
important in regard to the development of newborn calves and the function of the
gastrointestinal tract. The secondary aim was to determine the percentage of active to
total ghrelin in milk and plasma.

4
LITERATURE REVIEW

Discovery of Ghrelin
The discovery of ghrelin was a surprising consequence of scientists’ studying
growth hormone and its releasing bioregulators. That was driven by the desire to find a
growth hormone releasing compound that could cure disorders associated with growth
hormone deficiency (Aimaretti et al., 2002). The goal was to find either an exogenous or
endogenous bioregulator to work on anterior pituitary somatotrope cells to release growth
hormone.
Several scientists conducted studies in opioid peptides and found that one of the
opioid derivatives (enkephalin) was the endogenous ligand for morphine receptor;
therefore several opioid peptides derivatives were synthesized in order to find a more
potent and less addictive drug to soothe pain (Kojima et al., 2001). In 1976, Bowers et al.
found a modified opioid peptide that had a growth hormone releasing activity, but the
effect was minor. Even though the effect was minimal, it triggered a search for synthetic
compounds that might mimic growth hormone releasing hormone (GHRH) (Bowers,
2012). Since then, many studies have been conducted to develop and improve a potent
synthetic growth hormone releasing compound and several peptides had been developed
to stimulate the release of growth hormone from cultured pituitary cells, but their effect
was minimal. However, some peptides were found to be more potent such as hexapeptide
(GHRP-6), which is one of several synthetic met-enkephalin analogs (Bowers, 2012).
This peptide stimulated the releasing of growth hormone in vivo and in vitro in all
cultured cells and all species of animals tested. As a result, it became the standard
reference compound, even though the developing GHRP-6 did not attract the attention of
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the scientific community for further research. This was because researches were focused
on studying the role of growth hormone releasing hormone from the hypothalamus to
control the release of growth hormone. GHRP-6 was thought to stimulate growth
hormone release in a mechanism similar to GHRH, but could not be verified without
experimental comparison between them. Comparative analysis of the mechanism of
action of GHRH and GHRP-6, demonstrated two different mechanisms, through two
different receptors, and two intracellular signaling pathways (Howard et al., 1996).
GHRP-6 and other growth hormone stimulating compounds are known as growth
hormone secretagogues (secretagogue is a substance that causes another substance to be
secreted) and since they differ in their chemical structure, they are divided into two
groups, peptidergic and non-peptidergic. They are known to stimulate growth hormone
release in a way distinct from GHRH pathway and bind to a different receptor, known as
an orphan receptor (Kojima et al., 2001). The term orphan receptor is a strategy to name
any newly identified receptor until identifying its natural or endogenous ligands. MK0677, a synthetic non-peptide molecule, binds with high affinity to the membrane of
cultured cells from rat pituitary gland. It was then purified and the receptor has been
identified, which become known as growth hormone secretagogues receptor (GHS-R)
(Pong et al., 1996). Since then many researchers have used GHS-R expressing cells to
find novel ligands. Several novel bioactive peptides have been used such as nociception,
hypocretin, and prolactin-releasing peptides (Bowers, 2012). Because GHS-R was known
to be expressed in the pituitary and hypothalamus, experiential studies focused on cell
extracts from brain tissue to find an endogenous ligand for GHSR. However, nothing of
significance was found.
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After screening several tissues other than the brain, Kojima et al. (1999) found
very strong activity from stomach tissue extracts that stimulated growth hormone release
through GHS-R. After further purification, using reverse-phase high performance liquid
chromatography (RPHPLC), the active peptide and the novel endogenous ligand to GHSR was identified (Kojima et al., 1999; Kojima et al., 2001). They used the term ghrelin,
which ghre is derived from the root of the word “ grow “ in the Proto-Indo-European
language (Bowers, 2012).

Ghrelin Gene and Biochemistry
Ghrelin is a 28 amino acid octanoylated peptide hormone and is the only naturally
occurring peptide with post translation modification by ser3 O-octanoylation (Kojima and
Kangawa, 2010). This modification is essential for ghrelin activity and subsequently,
activation of its specific receptor. Preproghrelin is a polypeptide precursor for ghrelin and
in human is encoded by a single-copy gene (GHRL) that is located on the short arm of
chromosome 3 (3p25-26) and organized into four coding exons and three introns
(Wajnrajch et al., 2000). Preproghrelin gene codes for a 117 amino acid long peptide
which includes a 23 amino acid signal peptide, 28 amino acid mature ghrelin, and a 66
amino acid tail (Bednarek et al., 2000). Ghrelin gene also codes for another bioactive
molecule besides ghrelin, obestatin, which is synthesized through alternative splicing or
from extensive post-translational modifications. Even though, ghrelin and obestatin are
obtained from the same gene, they have opposing effects (Zhang et al., 2005). The
sequence of ghrelin amino acid is highly conserved between different species with
difference in two amino acid residues between human and rat (Kojima et al., 1999).
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Ghrelin has been identified in many species such as human, mouse, swine, frog,
fish, and chicken. In general, the chemical structure is similar among species and more
important, the active part of ghrelin peptide at the serine residue is conserved between
fish and mammals. Interestingly, chicken ghrelin has an opposite effect on feed intake; it
reduced food intake (Saito et al., 2002)

Ghrelin Tissue Distribution
Ghrelin was first isolated from the stomach and then from different types of
endocrine cells in other tissues. Ghrelin cells in the stomach are round or ovoid cells
close to the capillaries. Ghrelin is found in the oxyntic gland in the stomach (fundus
region which is the acid secreting part of the stomach). In a study conducted on rats, the
concentration of ghrelin decreased by 80% in the circulation after surgical removal of the
acid producing part of the stomach suggesting that the oxyntic mucosa is the major
source of ghrelin (Dornonville de la Cour et al., 2001). A reduction in circulating ghrelin
was also seen in a patient following gastrectomy (Leonetti et al., 2003).
Some of ghrelin secreting cells are found in the small and large intestine and
produce about 30% of circulating ghrelin, although the majority originate from the
stomach (Ariyasu et al., 2001; Krsek et al., 2002; Krsek et al., 2003). There are two types
of ghrelin cells in the lower gastrointestinal tract. One type with no contact with the
lumen, similar to those in the stomach, and the other one has elongated cells and is open
to the lumen (Sakata et al., 2002).
Expression of ghrelin at the mRNA or protein level, or both has also been
identified in several tissues other than gastrointestinal tract. The hypothalamic nuclei and
their axon terminals have been shown to express ghrelin peptide (Kojima et al., 1999;
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Korbonits et al., 2001a; Cowley et al., 2003; Toshinai et al., 2003). Ghrelin expression
has been shown in the pituitary (Korbonits et al., 2001a), kidney (Mori et al., 2000),
placenta (Gualillo et al., 2001), immune cells (Hattori et al., 2001), the ovary (Caminos et
al., 2003; Gaytan et al., 2003), testis (Barreiro et al., 2002), lung (Volante et al., 2002),
and in the pancreas (Date et al., 2002). Ghrelin mRNA expression was also identified in
tumor tissues at different levels, suggesting that it might play a role in tumor cells
development (Korbonits et al., 2001b; Gnanapavan et al., 2002; Iwakura et al., 2002).

Ghrelin Receptor
Ghrelin binds to growth hormone secretagogue receptor (GHS-R). There are two
different forms of the ghrelin receptor GHS-R–GHS-R1a and GHS-R1b (Kojima et al.,
1999; Petersenn et al., 2001). Ghrelin binds only to GHS-R1a which is a G proteincoupled receptor, with seven transmembrane domains (Kojima et al., 1999) while GHSR1b is a 289 amino acid, five-transmembrane domain, truncated receptor that is unable to
bind ghrelin (Howard et al., 1996). GHS-R1a is described as the functional ghrelin
receptor and mostly expressed in hypothalamic cells (Zigman et al., 2006; Lopez et al.,
2008). GHS-R1a expression is also shown in the pituitary gland and outside the CNS in
the thyroid, heart, lungs, intestines, pancreas, adrenal gland, testicles and ovaries (van der
Lely et al., 2004). In humans the GHS-R amino acid sequence was found to be about
52% identical to the G protein-coupled receptor for motilin (GPR38) (Feighner et al.,
1999). Ghrelin shares some similarity with motilin, both are synthesized in the upper
gastrointestinal tract, have growth hormone releasing activity and stimulate gastric
motility (Samson et al., 1984; Masuda et al., 2000).
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In order for ghrelin to bind to its functional receptor, ghrelin must be posttranslationally modified by a specific enzyme, ghrelin O-acyltransferase (GOAT). GOAT
facilitates the modification by adding an octanoyl group to the serine residue which is the
third amino acid of ghrelin (Gutierrez et al., 2008; Yang et al., 2008). Therefore, there are
two forms of ghrelin; octanoylated form (active form) and non-octanoylated form. Nonoctanoylated, also called des-acyl ghrelin, circulates in the plasma at higher levels than
octanoylated ghrelin (Hosoda et al., 2000b) and has effects other than growth hormone
releasing activity because it is unable to bind to GHS-R1a receptor. It has been
hypothesized that des-acyl ghrelin has other functions and has an alternative ghrelin
receptor that mediates the actions of des-ghrelin (Bang et al., 2007; Beasley et al., 2009).

Regulation of Ghrelin
Regulation of ghrelin and its effects happen at different levels. The body regulates
ghrelin by modifying the secretion rate from its cells in the stomach, the transcription and
translation of the ghrelin gene, expression of the ghrelin receptors and intracellular
signaling (van der Lely et al., 2004). The level of ghrelin is not stable in the circulation
and fluctuates during the day; being high after fasting and low after food intake. Ghrelin
level in the circulation is also affected by the time of the day and reaches its highest level
during the night, then declines later in the day (Cummings et al., 2002; Chan et al., 2004).
Fasting is the most effective regulator of ghrelin. The increased pulse frequency and
pulse amplitude during fasting, in addition to low leptin level in the circulation, create a
powerful orexigenic effect and stimulate gastric activity to increase ghrelin synthesis and
secretion (Bagnasco et al., 2002). In cows, the level of ghrelin concentration was
significantly decreased by about one hour after feeding, and then recovered to the
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previous level before feeding (Hayashida et al., 2001). Accordingly, ghrelin level is
generally high before food intake and during the night then declines immediately after
food intake and during the day. A number of studies have shown that restricting nutrient
intake by decreasing DMI of a high-energy diet results in increased plasma ghrelin
concentrations (Tschop et al., 2000; Monteleone et al., 2003). In steers, ingredient
composition and quantity of DMI did not influence plasma ghrelin concentrations as long
as positive energy balance was maintained (Wertz-Lutz et al., 2007).
Physical expansion of the stomach is not the trigger of ghrelin release. In a study
in rats, the ghrelin levels decreased when the stomach was filled with 50% glucose
solution. On the other hand, no changes were seen when the same volume of water was
used to fill the stomach to cause physical expansion (Tschop et al., 2000). Gastric
emptying and intestinal absorption of nutrients, especially glucose, are essential to cause
a decline in circulating ghrelin (Williams et al., 2003) and suggests an involvement of a
post gastric factor.
In human subjects, a significant drop in ghrelin level was seen after eating a diet
high in carbohydrates, but no similar effect occur after eating a diet high in fat
(Monteleone et al., 2003). The effect of carbohydrates and glucose on ghrelin level may
not be direct and could be mediated by other factors, such as insulin. Intravenous infusion
of insulin showed an inhibitory effect on ghrelin level in rats (McCowen et al., 2002). A
study tested the effect of insulin on ghrelin suppression in human by using different doses
and found a positive correlation between the insulin doses and reduction in plasma
ghrelin (Anderwald et al., 2003).
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Leptin and ghrelin are major hormones involved in the regulation of hunger and
satiety. Ghrelin stimulates hunger, while leptin causes satiety. Leptin may also play a role
in ghrelin regulation through positive or negative feedback loops and are either direct or
indirect. In an experiment with mice, administration of leptin stimulated expression of
mRNA of ghrelin in the stomach cells (Toshinai et al., 2001). In contrast, administration
of leptin to six patients did not regulate ghrelin over several hours to a few days,
suggesting that leptin does not regulate ghrelin levels independently (Chan et al., 2004).
Growth hormone has been suggested to have an inhibitory effect on ghrelin level.
Administration of a large dose of GH to normal rats resulted in a 50% decrease of ghrelin
levels in the plasma (Tschop et al., 2002).

Physiological Function of Ghrelin
Ghrelin is a hormone with multiple functions. It is mainly secreted from the
stomach mucosa and has paracrine and endocrine effects. It is well known as a peptide
with growth hormone releasing activity and appetite inducing factor. In addition to that,
the biological functions of ghrelin are much more diverse. It has effects on several
systems such as the gastrointestinal tract, energy homeostasis and glucose release,
reproduction, enzyme release, cell proliferation and apoptosis, and other functions.
The role of ghrelin in food intake is mediated through the hypothalamus and
different pathways that have been suggested to explain how ghrelin induces appetite. The
primary pathway is that ghrelin is released into the blood from the stomach, crosses the
blood brain barrier, and binds to its receptors in the hypothalamus (Banks et al., 2002).
Ghrelin also may reach the brain through the vagal nerve and stimulate the appetite center
(Ueno et al., 2005). In addition, ghrelin has a paracrine effect where it is produced locally
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in the hypothalamus and directly affects some appetite center (Cowley et al., 2003).
Ghrelin stimulates the activity of neurons expressing NPY, a neuropeptide that acts as a
neurotransmitter in the brain, and increases food intake and storage of energy (Kamegai
et al., 2001).
Ghrelin plays a significant function in stimulating growth hormone from the
hypothalamus. Several studies have shown the in vitro and in vivo GH-releasing activity
of ghrelin in rats, pigs and humans (Date et al., 2000b; Hataya et al., 2001; Hashizume et
al., 2003). The GH-releasing effect of ghrelin depends on the existence of GHSR-1a
which has a different mechanism of action to release growth hormone from somatotropic
cells in the anterior pituitary gland than that of GHRH-R. Ghrelin acts on the GHS-R1a
and causes increased intracellular calcium, which stimulates GH release. In some studies,
the GH-releasing activity of ghrelin was comparable to that of GHRH when injected
intravenously into rats (Kojima et al., 1999; Arvat et al., 2000; Takaya et al., 2000).
Furthermore, ghrelin showed three times more stimulation of GH-release than that of
GHRH (Arvat et al., 2000). Stimulation of GH release by ghrelin was positively
correlated with dose administered both in vitro and in vivo (Peino et al., 2000).
Adminstration of ghrelin intracerebroventricularly increased plasma GH concentration in
rats in a dose-dependent manner (Date et al., 2000b). Accordingly,
intracerebroventricular injection of ghrelin seems to be a more potent route than
intravenous administration. Administration of ghrelin and GHRH showed a synergistic
effect on GH secretion that resulted in more GH release than either GHRH or ghrelin
alone (Arvat et al., 2001; Hataya et al., 2001).
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In the gastrointestinal tract, ghrelin stimulates gastrointestinal motility, accelerates
gastric emptying, and regulates gastric acid secretion (Depoortere et al., 2005; Kitazawa
et al., 2005; Ariga et al., 2007). Administration of ghrelin, via the stomach tube in piglets,
resulted in significant changes in small intestine morphometry and mucosal development
and remodeling. These changes were dependent on the dosage of ghrelin administered
(Slupecka et al., 2012).
In the cardiovascular system ghrelin was observed to have treatment-potential for
severe chronic heart failure (CHF) and cardiac cachexia (Akashi et al., 2009). Also it has
been found that early treatment with ghrelin prevented the increase in cardiac
sympathetic nerve activity (CSNA) after acute myocardial infarction and improved
cardiac function in rats (Schwenke et al., 2008). Ghrelin also showed increased
contractile effect on guinea pig papillary muscle, renal artery, and vascular smooth
muscle (Mladenov et al., 2006; Dimitrova et al., 2007). Involvement of ghrelin in
cardiovascular system homeostasis suggests that ghrelin can be considered as a possible
therapeutic target for many pathological conditions associated with cardiovascular
damage and remodeling (Isgaard, 2013).
Ghrelin is involved in cell proliferation and apoptosis through different pathways
and may function as a protective factor against cells damage. Ghrelin promoted
endothelial cells proliferation (Rossi et al., 2008) and inhibited apoptosis of
cardiomyocytes and endothelial cells in vitro (Baldanzi et al., 2002). In porcine ovarian
granulosa cells, ghrelin reduced apoptosis-related substance-MAP3K5 accumulation and
promoted the cell proliferation (Sirotkin et al., 2008). Ghrelin is also involved in the
release of some enzymes and has been shown to stimulate amylase release from acinar
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cells in rats (Nawrot-Porabka et al., 2007) and increases aromatase activity in porcine
follicles after treatment with ghrelin (Rak and Gregoraszczuk, 2008).
Several studies showed that ghrelin gene is expressed in human (Gaytan et al.,
2004) and mouse testis (Tanaka et al., 2001), and rat Leydig cells and ovary (TenaSempere et al., 2002; Caminos et al., 2003). Also the ghrelin receptor, GHS-R1a, was
found in human (Gaytan et al., 2003; Gaytan et al., 2004) and rat (Tena-Sempere et al.,
2002; Barreiro et al., 2003) testis tissue. Administration of ghrelin in rodents appeared to
inhibit luteinizing hormone (LH) (Fernandez-Fernandez et al., 2004; Martini et al., 2006;
Harrison et al., 2008) and gonadotropin-releasing hormone (GnRH) secretion in vivo
(Fernandez-Fernandez et al., 2005), while follicle-stimulating hormone (FSH) remained
unaffected (Fernandez-Fernandez et al., 2007). Treating pituitary cells in vitro with
ghrelin stimulated LH and FSH release (Fernandez-Fernandez et al., 2005; FernandezFernandez et al., 2007). Treatment with ghrelin increased the secretion of prostaglandin F
(PGF), and E (PGE) in porcine granulosa cells culture (Sirotkin et al., 2008). Also,
ghrelin induced estradiol secretion, cell proliferation and decreases caspase-3 activity in
cultured whole porcine follicles (Rak et al., 2009).

Ghrelin in Milk
Milk is the main source of nutrition for the newborn calves and it contains a
variety of biologically active nutrients and hormones that provide immediate benefit.
Ghrelin has been identified in the human breast milk and its mRNA has been found in
several human tissues including mammary glands (Aydin et al., 2006; Kierson et al.,
2006). Even though the ghrelin hormone is produced and secreted by the mammary
gland, it has been suggested it comes mainly from the plasma although, in a lower
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amount (Aydin et al., 2006). Another study showed that the level of ghrelin in milk is
higher than the plasma (Kierson et al., 2006). The active form of ghrelin hormone also
has been identified in the human milk and found to be positively correlated to the serum
ghrelin of breast fed infants (Ilcol and Hizli, 2007). No literature has been found
regarding the level of ghrelin in cow’s milk. However, there is one indirect reference
about total ghrelin in the cow milk about 2.82 ng/ml (Savino et al., 2011). In other
animals, ghrelin has been measured in the colostrum and milk of the sow and found to be
6.73 ng/mL and 0.242 ng/mL, respectively (Woliński et al., 2013).

Acylated and des-acylated ghrelin
Ghrelin hormone exists in the stomach, hypothalamus and circulation as two
major endogenous forms, a form acylated at serine 3 (active ghrelin) and a des-acylated
form (des-acyl ghrelin). The acylated form is the active form since acylation is necessary
for the binding of ghrelin to the GHS-R1a (Hosoda et al., 2000b). The des-acylated form
of ghrelin exists at a higher level in blood than that of the active from (Soares and LeiteMoreira, 2008). Des-acyl ghrelin is the precursor form of active ghrelin. Activation of
ghrelin is by a post-translational modification catalyzed by GOAT. It is a polytopic
membrane-bound enzyme that attaches octanoate to serine-3 of ghrelin (Yang et al.,
2008) and is highly expressed in the stomach, the main source of ghrelin (Gutierrez et al.,
2008). Since the majority of circulating ghrelin is des-acylated, not all newly synthesized
ghrelin is modified by GOAT. It has been suggested that GOAT modifies most of ghrelin
synthesized and des-acylation happens later in the circulation by plasma esterase. Ghrelin
is transported in the plasma by binding to high-density lipoproteins (HDLs) that contain a
plasma esterase, paraoxonase and clusterin (Beaumont et al., 2003). These enzymes break
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the fatty acid chain that is attached to the Ser3 of ghrelin. Therefore, des-acyl ghrelin may
exist as either a pre form of non-modified ghrelin or the product of its deacylation by
plasma enzymes (Kojima and Kangawa, 2005).
Des-acyl ghrelin does not displace active ghrelin at the binding sites of GHS-R1a
in the hypothalamus and pituitary and shows no GH-releasing or other endocrine
activities in rats (Hosoda et al., 2000a). Des-acyl ghrelin does not appear to possess any
endocrine activities which raises the question as to if there is a specific receptor for desacyl ghrelin and whether des-acyl ghrelin has specific functions different from that of
acyl-modified ghrelin (Kojima and Kangawa, 2005). It has been reported that des-acyl
ghrelin shares with active acylated ghrelin some non-endocrine activities, including the
modulation of cell proliferation and some adipogenesis effect (Cassoni et al., 2004).
These two forms show some dissimilarity and one of the main differences between these
two forms is that only the des-acylated form can pass the blood brain barrier (Banks et
al., 2002). Several studies suggested that des-acyl ghrelin and acylated ghrelin had the
inverse effects on gastric emptying and small intestinal transit and motility through
different receptors (Fujino et al., 2003; Chen et al., 2005; Fujimiya et al., 2008).
Administration of ghrelin or des-acyl ghrelin increased plasma glucose and were
involved in glucose metabolism in humans and rats (Miljic et al., 2007; Broglio et al.,
2008; Vestergaard et al., 2008). However, des-acyl ghrelin counteracted the stimulatory
effect of acylated ghrelin on glucose release (Gauna et al., 2005). These findings suggest
that these two forms of ghrelin are likely to play opposite roles in glucose metabolism. In
general, both forms are present in various tissues and seem to have major physiological
role. The function of the acylated form (active form) has been studied intensively, and
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several of its biological roles have been identified since it has a known receptor. The
biological function of the des-acylated form remains unclear although it circulates in the
body in greater amounts than acylated ghrelin.
The presence of ghrelin in milk suggests that it is a critical compound for the
metabolic activity of newborn calves and functions transiently to regulate the activity of
some physiological processes until the endocrine system of the new calves start to
function independently.
To our knowledge, the effect of ghrelin on calves has not yet been studied and the
amount of ghrelin in bovine milk has not been identified in a detailed study. Savino et al.
(2011) measured ghrelin level of non-pasteurized cow’s milk to compare with breast milk
and some milk formula. The total ghrelin in the cow’s milk was reported to be 2.82
ng/ml. Several studies have identified ghrelin plasma level in cattle (Jennings et al., 2011;
Borner et al., 2013; Field et al., 2013; Ozturk et al., 2013), but none of these have
determined the relation between milk ghrelin and plasma ghrelin, or the ratio between
acylated (active ghrelin) and des-acylated ghrelin in cattle.
The primary aim of the present study was to investigate the level of ghrelin
concentrations in colostrum, transitional milk, early lactation mature milk, and midlactation milk and plasma. The colostrum and milk of the first week are particularly
important in regard to the development of newborn calves and the function of the
gastrointestinal tract. The secondary aim was to determine the percentage of active to
total ghrelin in milk and plasma.
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MATERIALS AND METHODS
This experiment was conducted at the Utah State University Caine Dairy
Research and Teaching facility. All procedures were reviewed and approved by the
Institutional Animal Care and Use Committee at Utah State University.
Fifteen Holstein cows were randomly selected and divided into 2 groups. The first
group were cows (n=10) from calving to 10 DIM, and the second group were cows (n=5)
from mid-lactation (average DIM = 227). Milk samples were collected twice daily (from
AM milking and PM milking) and plasma samples were collected once daily after PM
milking. Collection started immediately after calving which was day 1 and stopped after
the PM milking of the day 10. Milk and plasma samples were collected twice for one day
from group two.
Milk and blood samples were grouped into 4 groups: colostrum (samples from the
first two days), transitional milk (day 3 to day 5), early lactation mature milk (day 6 to
day 10), and mid-lactation.

Samples Collection and Storage
Blood samples were drawn into evacuated glass tubes containing EDTA and
taken to the lab. Plasma was immediately harvested via centrifugation at 2,300 x g for 15
min at 5 ± 2 oC. Collected plasma samples were frozen and stored at -80°C until further
analysis.
Milk samples were collected into 100 ml containers and kept refrigerated until
taken to the lab. From each milk sample, about 50 ml was transferred into another
container containing milk preservative and analyzed for lactose %, protein %, fat %, milk
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urea nitrogen (MUN), and somatic cell count (SCC) (Rocky Mountain DHIA lab,
Providence, UT). About 10 ml of the remaining milk was transferred into a plastic tube
and centrifuged at 4000 x g for 15 min at 5 ± 2 oC. After centrifugation, the fat layer was
removed and milk was transferred into another clean tube and stored frozen at -80°C until
further analysis.

Ghrelin Analysis
Plasma and milk ghrelin concentrations were measured by using two
commercially available ELISA kits for active and total forms of ghrelin (Millipore Corp;
Billerica, MA, USA). The kit was for rat ghrelin and has been used and validated to
detect bovine ghrelin in other studies (Miura et al., 2004; Field et al., 2013). All samples
were immediately treated after thawing with 1 mg of AEBSF, a protease inhibitor, for
each ml of sample and acidified with HCL to a final concentration of 0.05 N following
manufacturer recommendations. AEBSF was used to inhibit the detrimental effect of
protease and acid was added to preserve the active side chain of the ghrelin. Extensive
testing in our laboratory showed that both are critical in determining ghrelin in milk and
plasma. Milk samples were centrifuged again at 3000 x g for 15 after acidification and
the liquid phase was used for ELISA test.
Active and total ghrelin ELISA plate were run simultaneously. A standard curve
was constructed for each form of ghrelin and two quality control standards were included
with each plate. The assay was considered acceptable if both quality control values fell
within the range determined by the manufacturer.
An ELISA plate reader was used to read the absorbance of the color change at
450 nm and 590 nm within 5 min of adding ELISA stop solution. Microsoft Excel was
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used to construct a graph reference from the measured absorbance on the Y-axis against
the concentrations of the known ghrelin standard on the X-axis. The concentration of the
unknown samples was calculated by comparing their absorbance to the standards.

Statistical Analysis
Data were analyzed using the Proc Corr, Proc Reg, and Proc Mixed procedures of
SAS, version 9.3 (SAS, Institute Inc., Cary, NC). Each cow was considered as the
experimental unit and analyzed as a repeated measure design over time (DIM). Least
squares means were computed and difference between means determined using the
Tukey-Kramer multiple comparisons test. Significant difference were determined as P <
0.05 and trends defined as P < 0.1.
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RESULTS AND DISCUSSION
This study measured the concentrations of active and total ghrelin in colostrum,
milk, and plasma during the first 10 days of lactation and at mid-lactation. Ghrelin
concentrations on the first day of lactation were significantly higher (P ≤ 0.05) than other
days (Table 1). Concentrations of milk ghrelin on the other days were not statistically
different due to the large variations. There were fluctuations in milk ghrelin
concentrations between morning and evening milking (Table 2), but no statistical
significance was found or clear pattern was demonstrated (Figure 1). This changes in
ghrelin concentrations during the day in milk might be influenced by other factors as
DMI or ration composition. However, in this experiment all fresh cows were fed the same
ration and kept under the same management condition, but feed intake was not
calculated.
Table 1. Least squares means of concentrations in milk of total and active ghrelin (pg/ml)
and percent of active for the first 10 days of lactation and mid-lactation.
Day
Active ghrelin
SEM
Total ghrelin
SEM
Percent active
a
a
1
13.79
97.68
16.6
158.8
984.0
2

91.2

13.28

593.0

94.11

15.3

3

87.6

13.52

514.5

95.72

17.5

4

66.0

13.79

400.0

97.69

17.2

5

108.0

13.52

735.3

95.72

16.4

6

61.5

13.52

467.2

95.72

17.3

7

75.1

13.52

534.4

95.72

15.2

8

67.5

13.52

390.4

95.72

19.2

9

119.0

13.52

768.4

95.72

20.2

10

71.6

13.52

455.6

95.72

19.5

mid

72.1

18.13

528.1

128.42

13.6

a

Superscript indicates significant difference within column (P < 0.05)

22

Table 2. Least square means concentration in milk of active and total ghrelin (pg/ml),
and percent active by morning and evening milking for the first 10 days of lactation and
mid-lactation.
Days
Total ghrelin
SEM
Active ghrelin
SEM
Percent active
in milk
AM
PM
AM
PM
AM
PM
1
765.8 1150.
165.79
125.8
184.3
23.41
17.0
16.3
6
2

598.8

595.4

165.79

94.1

90.5

23.41

15.3

15.4

3

564.5

464.4

165.79

91.4

83.7

23.41

17.7

17.3

4

425.8

380.2

165.79

65.7

65.9

23.41

15.4

19.3

5

748.8

721.6

165.79

114.8

101.2

23.41

16.0

16.8

6

316.2

618.2

165.79

50.3

72.6

23.41

19.0

16.0

7

388.4

680.4

165.79

64.7

85.6

23.41

15.8

14.4

8

328.9

451.8

165.79

54.8

80.1

23.41

20.2

18.8

9

593.3

943.5

165.79

92.2

146.7

23.41

17.3

25.2

10

460.5

450.7

165.79

83.3

59.8

23.41

19.0

18.8

227

479.7

576.5

222.42

67.3

76.9

31.41

14.6

12.9

900
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600
500

Total

400

Active

300
200
100
0
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Transitional milk

Early lactation

Mid‐lactation

Figure 1. Total and active ghrelin concentrations (pg/ml) in milk between colostrum,
transitional milk, early lactation mature milk, and mid-lactation milk.
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One of the objectives of this study was to quantify the concentration of ghrelin in
dairy cow’s milk. Based on our findings, concentrations of total ghrelin seem to fall in a
range of 0.316 - 1.150 ng/ml. This appears to be lower than what was listed in the Savino
et al. (2011) study where the total ghrelin was measured from the milk of 5 different
cows to be compared with human breast milk ghrelin. In that study, total ghrelin averaged
was 2.82 ± 0.219 ng/ml; although no other details were provided about the lactation
status of those cows.
In our study, active and total ghrelin were measured to determine if there is a
correlation between them. No significant differences were found in the relationship
between active and total ghrelin, determined as a percentage (Table 1), across the first ten
days of lactation as well as mid-lactation. This finding, suggests that there is a predictable
ratio between active and total ghrelin in milk. The active milk ghrelin was about 17 ± 3 %
of total ghrelin. Such a ratio might help in determining the rate of acylation of inactive
ghrelin by ghrelin O-acyltransferase (GOAT) (Yang et al., 2008) in ghrelin producing
tissues or the rate of des-acylation of active ghrelin by plasma esterase during circulation
(Beaumont et al., 2003).
Milk was classified into four groups; colostrum, transitional milk, mature milk of
early lactation, and mature milk of mid lactation (Figure 1). The concentrations of total
and active ghrelin were higher in colostrum than other groups. This finding suggests that
ghrelin in colostrum might play a role in regulating newborn calf’s endocrine function
and stimulates appetite. No significant correlation was found between milk volume and
the concentration of ghrelin.
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The concentrations of active and total ghrelin were also measured in plasma
(Table 3). The level of ghrelin of both active and total was higher in the first 2 days of
lactation (during colostrum production), but was not significantly different (Figure 2).
The slight elevation of ghrelin concentration might be due to appetite stimulation in the
first few days of lactation.
Table 3. Least square means of total and active plasma ghrelin concentrations (pg/ml) in
the first 10 days of lactation and mid-lactation.
Day
Total ghrelin
SEM
Active ghrelin
SEM
Percent active
1

696.9

161.89

108.6

22.20

15.3

2

921.4

161.89

140.6

22.20

15.8

3

612.7

161.89

87.1

22.20

14.1

4

695.5

161.89

107.5

22.20

15.9

5

507.5

161.89

84.3

22.20

16.5

6

410.6

161.89

55.9

22.20

15.2

7

558.0

161.89

81.7

22.20

16.3

8

411.0

161.89

65.4

22.20

16.5

9

759.3

161.89

93.2

22.20

14.5

10

673.7

161.89

98.2

22.20

16.9

mid

489.5

217.20

70.3

29.79

14.2

The ratios between active and total plasma ghrelin (Table 3) were not
significantly different between days. The percentage of active plasma ghrelin to total was
about 15 ± 1.5 %. This conserved ratio could be used to calculate the concentration of
total ghrelin if the active concentration is known and vice versa.
No correlation was found between plasma and milk active to total ghrelin percentage
(Figure 3). This suggests that the percentage between active and total plasma ghrelin
cannot be used to measure the relation between active and total milk ghrelin and vice
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versa. As shown in Figure 4, there is a similar pattern between the percentage of active to
total between blood and milk ghrelin, but may differ in early lactation milk.
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800
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Total
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Active

300
200
100
0
Colostrum

Transitional milk

Early lactation

Mid‐lactation

Figure 2. Total and active ghrelin concentrations (pg/ml) in plasma between colostrum,
transitional milk, early lactation, and mid-lactation.

Figure 3. Correlation between the percentage of active to total milk ghrelin and the
percentage of active to total plasma ghrelin.
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Figure 4. Least square means of percent active to total ghrelin in milk and plasma.
Scatter plot from SAS output shows the relationship between active and total
ghrelin in milk and plasma. The correlation was positive (R2 = 0.898) for milk (Figure 5)
and plasma (R2 = 0.869) (Figure 6). No significant correlation was found between milk
active and plasma active ghrelin or between milk total and plasma total ghrelin (Figure 7)
(Figure 8).

Figure 5. Correlation between active and total milk ghrelin.
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Figure 6. Correlation between active and total plasma ghrelin.

Figure 7. Correlation between active plasma ghrelin and active milk ghrelin.
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Figure 8. Correlation between plasma total ghrelin and milk total ghrelin.
Least square means for milk composition and yield per day are shown in Table 4.
No significant correlations were found between active or total milk ghrelin and any milk
composition parameter except milk protein percent (Table 5); which was significant (P <
0.05) and positive.
Table 4. The least square means per day of milk yield kg, fat %, protein %, lactose %,
SCC (cells/ml; x 1000), and MUN (mg/dL).
DIM
Milk yield Fat % Protein % Lactose %
SCC (cells/ml; x
MUN
1000)
(mg/dL)
1
8.4
4.19
8.58
3.52
836
9.7
2
12.8
4.91
4.99
3.97
1165
11.4
3
12.7
5.87
4.16
4.05
851
13.9
4
14.4
7.18
3.85
3.93
903
11.2
5
15.5
6.03
3.62
4.12
874
10.5
6
17.3
5.58
3.45
4.34
800
9.3
7
18.0
5.22
3.37
4.44
487
8.7
8
18.9
5.34
3.31
4.45
497
9.0
9
18.2
5.12
3.26
4.45
364
8.9
10
19.6
4.50
3.14
4.57
498
9.3
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Table 5. Correlation coefficients between milk active and total ghrelin (pg/ml) and milk
yield, fat%, protein%, lactose%, SCC (cells/ml; x 1000), and MUN (mg/dL).
Milk Fat% Protein Lactose
SCC,
MUN
Total
Active
yield
%
%
cells/ml, mg/dL ghrelin ghrelin
x1000
-0.249
-0.251
0.461
-0.192
-0.118
-0.055
-0.060
Milk yield
-0.249
-0.145
-0.292
-0.075
0.025
-0.085
-0.099
Fat%
-0.251 -0.145
-0.629
0.210
-0.013
0.253
0.313
Protein%
0.461
-0.292
-0.629
-0.631
0.021
-0.080
-0.075
Lactose%
0.210
-0.631
-0.194
-0.003
-0.031
SCC, cells/ml, -0.192 -0.075
x1000
-0.118
0.025
-0.013
0.021
-0.194
-0.048
0.019
MUN mg/dL
-0.055 -0.085
-0.080
-0.003
-0.048
0.253
0.947
Total ghrelin
-0.060 -0.099
-0.075
-0.031
0.019
0.313
0.947
Active ghrelin
*Coefficients that are bold are significant at P < 0.05.
We saw no correlation between ghrelin and milk fat; however, Kierson et al.
(2006) found a direct correlation between total milk ghrelin levels and estimated milk fat
content (r =/0.84). No one has shown a correlation with milk protein percent. We do not
know if this is a direct or indirect effect. Milk volume showed no correlation between
active and total milk ghrelin (Table 5).
There was a noticeable variation in ghrelin concentration among cows in the first
10 days of lactation. Several factors such as body condition, health, feed intake, lactation
number could be involved in controlling ghrelin concentration in plasma and milk. In this
study, we focused on the time factor (day 1 to day 10 and mid-lactation) because all cows
were generally similar in age, previous production, and same ration and housed under the
same conditions. We did not account for DMI in our experiment which may explain
some of this variation. Many dairy cows experience negative energy balance in early
lactation due to decreased feed intake which may affect ghrelin concentration.
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Regardless of other factors that may contribute to ghrelin concentration, in our
experiment ghrelin concentration was significantly higher in colostrum. This was
significant and probably plays a role in controlling the appetite of newborn calves and
stimulates growth. Consuming ghrelin in colostrum can induce an orexenic effect through
ghrelin receptors GHS-R1b that are distributed and highly expressed along the GIT. Oral
administration of ghrelin has shown a significant effect on piglets’ growth and
development of intestinal mucosa (Słupecka et al., 2012). Calves at this stage of life are
monogastrics and do not develop a rumen until later. No study has shown the effect of
oral administration of ghrelin in ruminant newborns, but we assume it is similar to
monogastrics. The physiological effect of ghrelin has shown no difference between
monogastrics and ruminants.
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CONCLUSION
Ghrelin is present in plasma and milk of dairy cows and milk ghrelin concentrations
were higher in the first day of lactation in both active and total forms than days 2 to 10 of
lactation. Colostrum had a higher concentration of ghrelin when compared with
transitional or mature milk of early or mid-lactation. No significant differences was
shown in ghrelin level between milk taken at morning and evening milking suggesting no
diurnal pattern in milk ghrelin.
The ratio between active and total ghrelin were constant and correlated. Active
ghrelin in milk was 17 ± 3 % of total ghrelin. Active and total plasma ghrelin were also
constant and correlated with each other. Active plasma ghrelin was 15 ± 1.5 % of total
plasma ghrelin. Such a ration can help in estimation of active or total ghrelin if either
form is known.
Active and total plasma ghrelin concentrations were simultaneously measured
with milk and no correlation was found between milk and plasma active or total ghrelin.
This finding suggests that the concentrations of ghrelin in blood and milk are somewhat
independent of each other. No relationship was observed between milk active and total
ghrelin and milk yield and milk composition except milk protein percent. We conclude
that milk ghrelin is found in large concentration in colostrum than other milk and
probably is important to calf nutrition.
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